# A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

> **NCT00938431** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 47 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Lacosamide

## Key facts

- **NCT ID:** NCT00938431
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2019-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938431, "A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00938431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*